From Risk to Readiness: How Smart CMC Strategy Defines Advanced Therapy Success
December 02, 2025
Advanced therapies present unique challenges from both a regulatory and a chemistry, manufacturing, and controls (CMC)...
Read more →Cell and gene therapies (CGTs) have advanced from conceptual promise to clinical reality, with dozens of approved products and thousands more in development. A unifying feature...
Read More →December 02, 2025
Advanced therapies present unique challenges from both a regulatory and a chemistry, manufacturing, and controls (CMC)...
Read more →November 12, 2025
CAR-T therapies have redefined cancer treatment, moving from bold hypothesis to frontline standard in less than a decade. With...
Read more →